Skip to main content
LobbyMap

American Pharma Holdings

Manufacturing · Lobbying Client

C
Influence Score
40/100
Moderate Influence
$1.1M
Total Lobby Spend
4
Policy Issues
1
Lobbyists
0
Revolving Door

American Pharma Holdings reported $1.1 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Manufacturing, Taxation, Trade. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Commerce
US Senate
Securities & Exchange Commission
Food & Drug Administration
Federal Aviation Administration
Dept of Transportation

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarSquire Patton Boggs LLP
TRD
1$80K
2020 Apr-JunBGR Group LLP
GOVTAXMAN+1
1$86K
2020 Jul-SepHolland & Knight LLP
TRDMAN
1$69K
2020 Oct-DecCassidy & Associates LLP
TRDMANTAX+1
1$65K
2021 Jan-MarBGR Group LLP
GOVTAXMAN+1
1$54K
2021 Apr-JunSquire Patton Boggs LLP
TAXGOVTRD
1$49K
2021 Jul-SepCassidy & Associates LLP
GOV
1$37K
2021 Oct-DecBGR Group LLP
TRDTAXGOV
1$34K

American Pharma Holdings Lobbying FAQ

American Pharma Holdings has spent $1.1M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

American Pharma Holdings lobbies on 4 policy issues, including Manufacturing, Taxation, Trade, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

American Pharma Holdings has an Influence Score of 40/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

American Pharma Holdings employs 1 registered lobbyists, of whom 0 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

American Pharma Holdings has contacted 6 government entities as part of their lobbying activities, including Dept of Commerce, US Senate, Securities & Exchange Commission.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.